These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29929982)

  • 21. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
    Marschall HU; Wagner M; Bodin K; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Sjövall J; Trauner M
    J Lipid Res; 2006 Mar; 47(3):582-92. PubMed ID: 16327028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.
    Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B
    Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
    Li X; Liu R; Luo L; Yu L; Chen X; Sun L; Wang T; Hylemon PB; Zhou H; Jiang Z; Zhang L
    Arch Toxicol; 2017 Jan; 91(1):481-494. PubMed ID: 27090119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesoid X receptor represses hepatic human APOA gene expression.
    Chennamsetty I; Claudel T; Kostner KM; Baghdasaryan A; Kratky D; Levak-Frank S; Frank S; Gonzalez FJ; Trauner M; Kostner GM
    J Clin Invest; 2011 Sep; 121(9):3724-34. PubMed ID: 21804189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting FXR in cholestasis: hype or hope.
    Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F
    Expert Opin Ther Targets; 2014 Dec; 18(12):1449-59. PubMed ID: 25200104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
    Pan X; Jeong H
    Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.
    Zhu L; Wang L; Cao F; Liu P; Bao H; Yan Y; Dong X; Wang D; Wang Z; Gong P
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):195-205. PubMed ID: 29360226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HNF4α Regulates CSAD to Couple Hepatic Taurine Production to Bile Acid Synthesis in Mice.
    Wang Y; Matye D; Nguyen N; Zhang Y; Li T
    Gene Expr; 2018 Aug; 18(3):187-196. PubMed ID: 29871716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
    Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; Taylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C
    Hepatology; 2010 Oct; 52(4):1341-9. PubMed ID: 20842631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
    Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
    Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
    Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
    Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of molecular docking and liver transcription sequencing analysis for the evaluation of salt-processed psoraleae fructus-induced hepatotoxicity in ovariectomized mice.
    Wu Y; Min L; Xu Y; Liu H; Zhou N; Hua Z; Mei C; Jiang Z; Li W
    J Ethnopharmacol; 2022 Apr; 288():114955. PubMed ID: 35032590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
    Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
    Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.